- Home
- SRZN vs MYNA Comparison
SRZN vs MYNA Comparison
Compare SRZN & MYNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRZN
- MYNA
- Stock Information
- Founded
- SRZN 2015
- MYNA 2009
- Country
- SRZN United States
- MYNA Germany
- Employees
- SRZN N/A
- MYNA N/A
- Industry
- SRZN Medicinal Chemicals and Botanical Products
- MYNA
- Sector
- SRZN Health Care
- MYNA
- Exchange
- SRZN Nasdaq
- MYNA Nasdaq
- Market Cap
- SRZN 38.1M
- MYNA 35.9M
- IPO Year
- SRZN N/A
- MYNA 2021
- Fundamental
- Price
- SRZN $8.99
- MYNA $1.36
- Analyst Decision
- SRZN
- MYNA
- Analyst Count
- SRZN 0
- MYNA 0
- Target Price
- SRZN N/A
- MYNA N/A
- AVG Volume (30 Days)
- SRZN 33.9K
- MYNA 36.1K
- Earning Date
- SRZN 11-06-2024
- MYNA 11-26-2024
- Dividend Yield
- SRZN N/A
- MYNA N/A
- EPS Growth
- SRZN N/A
- MYNA N/A
- EPS
- SRZN N/A
- MYNA N/A
- Revenue
- SRZN $10,000,000.00
- MYNA $5,957,776.00
- Revenue This Year
- SRZN N/A
- MYNA $216.03
- Revenue Next Year
- SRZN N/A
- MYNA $267.22
- P/E Ratio
- SRZN N/A
- MYNA N/A
- Revenue Growth
- SRZN N/A
- MYNA 21.89
- 52 Week Low
- SRZN $6.00
- MYNA $0.66
- 52 Week High
- SRZN $16.19
- MYNA $7.58
- Technical
- Relative Strength Index (RSI)
- SRZN 45.92
- MYNA 51.92
- Support Level
- SRZN $8.10
- MYNA $1.36
- Resistance Level
- SRZN $10.76
- MYNA $1.48
- Average True Range (ATR)
- SRZN 1.25
- MYNA 0.09
- MACD
- SRZN -0.16
- MYNA 0.00
- Stochastic Oscillator
- SRZN 22.90
- MYNA 55.00
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
About MYNA Mynaric AG American Depository Shares
Mynaric AG operates in the communication equipment business sector. The company is engaged in the manufacture and sale of products and projects and the provision of services in the field of laser technology, in particular in the aerospace, telematics, and satellite services sectors. It operates in two segments: Air and Space. The space segment comprises CONDOR terminals, and the Air segment comprises HAWK terminals. The company's product portfolio consists of Optical ground stations, Air-to-ground terminals, Air-to-air terminals, Space terminals, and Custom products and subcomponents. Its applications consist of high-altitude networks, remote eyes, satellite constellations, earth observation satellites, and others. Geographically, its key revenue is derived from the United States.